BridgeMD
STOP-COPD Standard vs Targeted Oxygen Therapy Prehospital for Chronic Obstructive Pulmonary Disease
EU CTIS ID: 2022-502003-30-00
What this study is testing
To determine whether prehospital titrated oxygen in patients with suspected AECOPD will decrease 30-day mortality compared to patients receiving standard care.
- Therapeutic use (Phase IV)
A plain-language read of the study's public EU CTIS listing. The study team confirms the details.
Who can take part
You may be able to join if
- Confirmed suspicion of COPD
- The treating EMT or Paramedic suspects AECOPD
- Patients over the age of 40 years
- Need of inhaled bronchodilators
You likely can't join if
- Non-COPD bronchospasm
- Known or suspected pregnancy
- Prehospital NIV, invasive or bag mask assisted ventilation
- Allergy to inhalation drug (Salbutamol)
- Transfer between hospitals
- More than 2 doses (5 mg salbutamol) inhalation drug, acute treatment by EMS personnel, before allocated treatment is initiated
See the full eligibility criteria
- Confirmed suspicion of COPD
- The treating EMT or Paramedic suspects AECOPD
- Patients over the age of 40 years
- Need of inhaled bronchodilators
- Non-COPD bronchospasm
- Known or suspected pregnancy
- Prehospital NIV, invasive or bag mask assisted ventilation
- Allergy to inhalation drug (Salbutamol)
- Transfer between hospitals
- More than 2 doses (5 mg salbutamol) inhalation drug, acute treatment by EMS personnel, before allocated treatment is initiated
- Readmission within 30 days from last randomization
- Suspicion of acute coronary syndrome (ACS)
- Prior decline to participate in the trial
The study team makes the final eligibility decision.
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 65+ years, 18-64 years. The study team makes the final eligibility decision.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from EU CTIS; the study team decides eligibility.